^○Kentaro YAMATO¹, Tatsuo MARUMOTO¹, Ken INADA², Minori ENOMOTO³, Masahiro TAKESHIMA⁴, Kazuo MISHIMA ⁴ (1. Japan Medical Office, Takeda Pharmaceutical Company Limited, 2. Department of Psychiatry, Tokyo Women's Medical University, 3. Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, 4. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

^○Ataru INAGAKI^{1, 2}, Sosei YAMAGUCHI³, Yasutaka OJIO³, Junko KOIKE³, Asami MATSUNAGA³, Makoto OGAWA³, Hiroyuki WATANABE^{4, 5}, Yoshiki KISHI⁶, Akiko KIKUCHI³, Chiyo FUJII³ (1. College of Education, Psychology and Human Studies, Aoyama Gakuin University, Tokyo, Japan, 2. Health Administration Center, Aoyama Gakuin University, Tokyo, Japan, 3. Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan, 4. Division of Medical Treatment and Rehabilitation, Center of Forensic Mental Health, Chiba University, Chiba, Japan, 5. Department of Psychiatry, Gakuji-kai, Kimura Hospital, Chiba, Japan, 6. Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan)

^○Taisuke YATOMI¹, Takahito UCHIDA², Hiroyoshi TAKEUCHI², Shin KURAMOCHI³, Masaru MIMURA², Hiroyuki UCHIDA² (1. Department of Neuropsychiatry, Kawasaki Municipal Hospital, 2. Department of Neuropsychiatry, Keio University School of Medicine, 3. Department of Psychiatry, Yamanashi Prefectural Kita Hospital)

^○Kentaro ONIKI¹, Keiji TAKATA², Yuki TATEYAMA³, Hiroki YASUDA⁴, Miu YOKOTA², Sae YAMAUCHI⁵, Junji SARUWATARI¹ (1. Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, 2. Division of Pharmacy, Sakurajyuji Hospital, Kumamoto, Japan, 3. Division of Nursing, Sakurajyuji Hospital, Kumamoto, Japan, 4. Division of Respiratory Medicine, Sakurajyuji Hospital, Kumamoto, Japan, 5. Division of Nutrition, Sakurajyuji Hospital, Kumamoto, Japan)

^○Takeya AOKI, Tadashi KAMEDA, Naotaka TSUCHIYA (Furoukai Hospital)

^○Mizue ICHINOSE^{1, 3}, Itaru MIURA¹, Taishi ASANO¹, Shinnosuke YAMAMOTO^{1, 5}, Masashi ITO^{1, 4}, Sho HORIKOSHI^{1, 6}, Haruka KANEKO^{1, 3}, Kenya WATANABE², Chihiro YAMAMOTO², Keiko NOZAKI¹, Hirooki YABE¹ (1. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan, 2. Department of Pharmacy, Fukushima Medical University Hospital, Fukushima, Japan, 3. Hoshigaoka Hospital, Fukushima, Japan, 4. Fukushima Prefectural Yabuki Hospital, Fukushima, Japan, 5. Fukushima Red Cross Hospital, Fukushima, Japan, 6. Ichiyokai Hospital, Fukushima, Japan)

^○Chika KUBOTA¹, Toshiya INADA², Ajit AVASTHI³, Kok-Yoon CHEE⁴, Andi Jayalangkara TANRA⁵, Shin-Ku LIN⁶, Naotaka SHINFUKU⁷ (1. National Center of Neurology and Psychiatry, 2. Department of Psychiatry, Nagoya University Graduate School of Medicine, 3. Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, 4. Department of Psychiatry & Mental Health, Kuala Lumpur Hospital, 5. Departemen of Psychiatry, Hasanuddin University, 6. Department of Psychiatry, Taipei City Hospital and Psychiatric Center, 7. Kobe University)

^○Yo KAWAGUCHI¹, Ryosuke SAITO², Shuntaro WATANABE², Natsuru WATANABE², Fumiaki AKAMA², Keiichiro TOMIYAMA², Kiyoshi SEKIGUCHI¹, Fumio KOUDA¹, Naoki TOMITA¹, Masahiko NISHIMOTO¹, Kengo MIURA¹, Kenji YAMAMOTO² (1. Soshu Hospital, 2. Tokai University School of Medicine)

^○YUI OKUBO¹, Hitoshi MAESHIMA², Keiko OTSUKA¹ (1. Department of Pharmacy,Juntendo University Kosigaya Hospital, 2. Department of Psychiatry,Juntendo University Kosigaya Hospital)

^○Naoki FUKUI¹, Yutaro SUZUKI^{1, 3}, Takuro SUGAI¹, Junzo WATANABE⁴, Shin ONO^{5, 6}, Nobuto TSUNEYAMA¹, Misuzu TAJIRI², Toshiyuki SOMEYA² (1. Department of Psychiatry, Niigata University Medical and Dental Hospital, 2. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 3. Suehirobashi Hospital, 4. Shironemidorigaoka Hospital, 5. Niigata Psychiatric Center, 6. Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences)

^○Takahiro NEMOTO¹, Takashi UCHINO¹, Sayaka AIKAWA¹, Satoshi MATSUO², Noriyuki MAMIYA², Yo WADA¹, Youji TAKUBO¹, Taiju YAMAGUCHI¹, Naoyuki KATAGIRI¹, Naohisa TSUJINO¹, Yoshiyuki SHIBASAKI², Tomohiro USAMI², Masafumi MIZUNO¹ (1. Department of Neuropsychiatry, Toho University School of Medicine, 2. Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd.)

^○Keisuke KUSUDO¹, Ryo OCHI², Shinichiro NAKAJIMA¹, Hiroyuki UCHIDA¹, Takefumi SUZUKI³, Fernando CARAVAGGIO⁴, Tarek K RAJJI⁴, Wanna MAR⁴, Philip GERRETSEN⁴, Benoit H MULSANT⁴, Bruce G POLLOCK⁴, Masaru MIMURA¹, David C MAMO⁵, Ariel GRAFF-GUERRERO⁴ (1. Keio University school of Medicine, Depertment of Neuropsychiatry, Tokyo, Japan., 2. Keio University, Faculty of Environment and Information, Yokohama, Japan., 3. University of Yamanashi, Department of Neuropsychiatry and Clinical Ethics, Kofu, Japan., 4. University of Toronto, Department of Psychiatry, Toronto, Canada., 5. University of Malta, Department of Psychiatry, Msida, Malta.)

^○Junya FUJINO^{1, 2}, Shisei TEI^{1, 2, 3, 4}, Takashi ITAHASHI¹, Yuta AOKI¹, Haruhisa OHTA^{1, 5}, Manabu KUBOTA^{1, 2, 6}, Ryu-ichiro HASHIMOTO^{1, 7}, Motoaki NAKAMURA^{1, 8}, Nobumasa KATO¹, Hidehiko TAKAHASHI^{1, 2, 9} (1. Medical Institute of Developmental Disabilities Research, Showa University, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, 3. Institute of Applied Brain Sciences, Waseda University, 4. School of Human and Social Sciences, Tokyo International University, 5. Department of Psychiatry, School of Medicine, Showa University, 6. Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 7. Department of Language Sciences, Graduate School of Humanities, Tokyo Metropolitan University, 8. Kanagawa Psychiatric Center, 9. Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University)

^○Takashi WATANABE^{1, 2, 3}, Norio FURUKORI³, Kazutaka SHIMODA³ (1. Keijikai Kikuchi Hospital, 2. Sakura La Medical Clinic, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine)

^○Keitaro KIMOTO, Yuki TAKAHASHI, Fumiaki AKAMA, Yuichi OHNISHI, Katsunaka MIKAMI , Hideo MATSUMOTO, Kenji YAMAMOTO (Department of Psychiatry,Tokai University,Kanagawa,Japan)

^○Tsuyoshi SASAKI^{1, 2}, Kenji HASHIMOTO³, Yutaka HOSODA¹, Yasunori ODA², Tomihisa NIITSU², Yuko FUJITA³, Youhei KAWASAKI⁴, Masaomi IYO^{1, 2, 3} (1. Department of Child Psychiatry, Chiba-University Hospital, 2. Department of Psychiatry, Graduate School of Medicine, Chiba University, 3. Chiba University Center for Forensic Mental Health, 4. Biostatistics Section, Clinical Research Center, Chiba University Hospital)

^○Masahiro TAKESHIMA, Kazuo MISHIMA (Department of Neuropsychiatry, Akita University Graduate School of Medicine)

^○Hiroshi YAMANAKA¹, Nobuhisa KANAHARA², Goro FUKAMI¹, Masaomi IYO³ (1. Chiba Psychiatric Medical Center, 2. Center for Forensic Mental Health, Chiba University, 3. Department of Psychiatry Graduate School of Medicine School of Medicine, Chiba University)

^○Hirokazu SHIMA¹, Jun ISHIGOOKA², Hiroshi NAKAMURA¹, Yoshihumi INOUE¹, Nakao IWATA³ (1. Sumitomo Dainippon Pharma Co.,Ltd., 2. Institute of CNS Pharmacology, 3. Fujita Health University School of Medicine)

^○Kenya WATANABE¹, Keiko NOZAKI², Itaru MIURA², Naoki MORITA³, Daisuke JINNO¹, Chihiro YAMAMOTO¹, Taishi ASANO², Mizue ICHINOSE^{2, 4}, Shinnosuke YAMAMOTO^{2, 5}, Haruka OCHIAI², Masashi ITO^{2, 6}, Sho HORIKOSHI^{2, 7}, Haruka KANEKO^{2, 4}, Keishiro IZUMI¹, Hirooki YABE² (1. Department of Pharmacy, Fukushima Medical University Hospital, Fukushima, Japan, 2. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan, 3. Fukushima Medical University School of Medicine, Fukushima, Japan, 4. Hoshigaoka Hospital, Fukushima, Japan, 5. Fukushima Red Cross Hospital, Fukushima, Japan, 6. Fukushima Prefectural Yabuki Hospital, Fukushima, Japan, 7. Ichiyokai Hospital, Fukushima, Japan)

^○Kiyokazu ATAKE¹, Yosuke KOSHIKAWA², Ryohei IGATA¹, Hirotaka TOMINAGA¹, Yuki KONISHI¹, Asuka KATSUKI¹, Hikaru HORI¹, Hiroki BANDO³, Shiho SAKAI², Keiichiro NISHIDA², Yuki KAGEYAMA⁴, Yoshiteru TAKEKITA², Reiji YOSHIMURA¹, Tadafumi KATO⁵, Masaki KATO² (1. Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan, 2. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan, 3. Seishokai Sephiroth Hospital, Shiga, Japan, 4. Department of Neuropsychiatry, Osaka City University, Graduate School of Medicine, Osaka, Japan, 5. Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan)

^○Nobuto TSUNEYAMA¹, Yutaro SUZUKI^{1, 2}, Hiroshi ARINAMI¹, Misuzu TAJIRI¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 2. Suehirobashi Hospital)

^○Norio FURUKORI^{1, 7}, Takashi TSUBOI^{3, 7}, Naoto ADACHI², Yokihisa KUBOTA², Hitoshi UEDA², koji EDAGAWA², Eiichi KATSUMOTO², koji AZEKAWA², Eiichiro GOTO², Seiji HONGO², Kazuhira MIKI², Masaki KATO^{4, 7}, Reiji YOSHIMURA^{5, 7}, Toshiaki KIKUCHI^{6, 7}, Atsuo NAKAGAWA^{6, 7}, koichiro WATANABE^{3, 7} (1. Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan, 2. Japanese Association of Neuro-Psychiatric Clinics, 3. Department of Psychiatry, Kyorin University , 4. Department of Psychiatry, Kansai Medical School, 5. Department of Psychiatry, Dokkyo Medical School, , 6. Department of Psychiatry, Keio University, 7. Japanese Society of Neuropsychopharmacology)

^○Hiroshi ARINAMI¹, Yuutarou SUZUKI^{1, 2}, Misuzu TAJIRI¹, Nobuto TSUNEYAMA¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences , 2. Suehirobashi Hospital)

^○Takeshi SUZUKI¹, Goyo NAGAI², Akifumi NAKAMURA^{2, 3}, Shoko KAGAWA², Kenji NEMOTO^{2, 4}, Kazuo MIHARA², Tsuyoshi KONDO² (1. Departments of Hospital Pharmacy, Graduate school of Medicine, University of the Ryukyus, 2. Departments of Neuropsychiatry, Graduate school of Medicine, University of the Ryukyus, 3. Akari clinic, 4. Iruka mental clinic)

^○Shoko KAGAWA¹, Takeshi SUZUKI², Goyo NAGAI¹, Akifumi NAKAMURA^{1, 3}, Kenji NEMOTO^{1, 4}, Kazuo MIHARA¹, Tsuyoshi KONDO¹ (1. Departments of Neuropsychiatry Graduate School of Medicine, University of the Ryukyus, Okinawa, 2. Hospital Pharmacy, Graduate School of Medicine, University of the Ryukyus, Okinawa, 3. Akari clinic, 4. Iruka mental clinic)

^○Ogata HARUHIKO^{1, 2}, Koichiro HIGASA³, Hidetoshi TAHARA⁴, Akira SHIMAMOTO⁵, Hiroki BANDOU², Shiho SAKAI¹, Yosuke KOSHIKAWA¹, Shinpei NONEN ⁶, Keiichiro NISHIDA ¹, Yoshiteru TAKEKITA ¹, Toshihiko KINOSHITA¹, Masaki KATO¹ (1. Department of Neuropsychiatry, Kansai Medical University , 2. Sephiroth Hospital, 3. Institute of Biomedical Science, Laboratory for Genome Analysis, Kansai Medical University, 4. Graduate School of Biomedical & Health Sciences, Hiroshima University, 5. Department of Pharmacy, Sanyo-Onoda City University, 6. Department of Pharmacy, Hyogo University of Health Sciences)

^○Akifumi NAKAMURA^{1, 2}, Goyo NAGAI¹, Shoko KAGAWA¹, Takeshi SUZUKI³, Kenji NEMOTO¹, Kazuo MIHARA¹, Tsuyoshi KONDO¹ (1. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan, 2. Akari Clinic, 3. Department of Pharmacy, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan)

^○Junichi GOTO², Yoshihiro NABESHIMA¹, Kazuya ISODA¹, Maiko IKEDA¹, Masakazu ICHIHASHI¹, Sachi YAMASHIRO¹, Masahiro SHONO¹, Kosuke NISHIYAMA¹, Kayoko KIFUJI¹, Akinori AIZAWA¹, Hiroko SUGAWARA³, Minoru TAKEBAYASHI³ (1. Yuge hospital, Kumamoto, Japan, 2. Kumamoto prefectual mental care center, Kumamoto, Japan, 3. Department of psychiatry faculty of life sciences kumamoto university, Kumamoto, Japan)

^○Chikashi TAKANO, Yoshiteru TAKEKITA, Masaki KATOU, Naotaka SUNADA, Yousuke KOSHIKAWA, Haruhiko OGATA, Toshiya FUNATSUKI, Tomoyo YANAGIDA, Minami NAITOU, Atsuko YAMAMOTO, Toshihiko KINOSHITA (Kansai medical University, Lab of psychiatry)

^○Toshiya FUNATSUKI¹, Haruhiko OGATA², Minami NAITO¹, Yosuke KOSHIKAWA¹, Yoshiteru TAKEKITA¹, Shiho SAKAI¹, Naotaka SUNADA¹, Keiichiro NISHIDA¹, Hiroki BANDO², Yoshiyuki HATASHITA², Shinpei NONEN³, Akira SHIMAMOTO⁴, Hidetoshi TAHARA⁵, Toshihiko KINOSHITA¹, Masaki KATO¹ (1. Department of Neuropsychiatry,Kansai Medical University,Moriguchi-city,Osaka,Japan , 2. Sephiroth Hospital, 3. School of Pharmacy,Hyogo University of Health Sciences,Hyogo,Japan, 4. Tokyo University of Science,Yamaguchi, 5. Department of Celluar and Molecular Biopsy,Graduate School of Biomedical and Health Science,Hiroshima University,Hiroshima,Japan)

^○Hideo KATO, Teruki KOIZUMI, Hiroyoshi TAKEUCHI, Masaru MIMURA, Hiroyuki UCHIDA (Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunovion Pharmaceuticals, Inc.)

^○Katsuhiko HAGI¹, Melissa P DELBELLO², Daisy Ng MAK³, Aditi KADAKIA³, Vincent HELLER⁴, Rajpal SINGH⁵, Tadashi NOSAKA¹, Antony LOEBEL³ (1. Sumitomo Dainippon Pharma Co., Ltd., 2. University of Cincinnati, College of Medicine, 3. Sunovion Pharmaceuticals, Inc., 4. Real-World Insights, IQVIA, 5. HEOR Scientific Services, IQVIA)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunovion Pharmaceuticals, Inc.)

^○Shinpei NONEN¹, Yoshiteru TAKEKITA², Toshihiko KINOSHITA², Kato MASAKI² (1. School of Pharmacy, Hyogo University of Health Sciences, Hyogo, Japan, 2. Department of Neuropsychiatry, Kansai Medical University)

^○Michina OKADA¹, Takamichi KOGURE^{1, 3, 4, 5}, Takanori KOMURO¹, Hideyuki NISHIDA¹, Shutaro SUGITA^{1, 2}, Takuya NAKASONE¹, Tomoyuki TACHIBANA^{1, 2}, Isao KASUGA¹, Yuji NISHI¹, Naoki HANAOKA¹, Makiko SUGAWA⁵, Masahiko SUMITANI⁴, Kazuo KAWAHARA⁵, Toru DAMBARA¹, Tadashi MURAKAMI¹ (1. Sanmaibashi Hospital, 2. Department of Psychiatry, School of Medicine, Showa University, 3. Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, 4. Department of Palliative Medicine, The University of Tokyo Hospital, 5. Department of Health Policy Science Tokyo Medical and Dental University Graduate School of Medical and Dental Science)

^○Itaru MIURA¹, Tadashi NOSAKA², Hirooki YABE¹, Katsuhiko HAGI² (1. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan, 2. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd.)

^○Tomoyo YANAGIDA, Naotaka SUNADA, Yuichi KITAURA, yositeru TAKEKITA, Tosihiko KINOSITA, Masaki KATO (Department of Neuropsychiatry, Kansai Medical University)

^○Jun ISHIGOOKA¹, Ken INADA², Kazuo AOKI³, Kazunari NIIDOME³, Shuichi IWASHITA³, Tomohiro USAMI³ (1. Institute of CNS Pharmacology, Japan, 2. Tokyo Women's Medical University, 3. Otsuka Pharmaceutical Co., Ltd.)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunovion Pharmaceuticals, Inc.)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunovion Pharmaceuticals, Inc.)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunivion Pharmaceuticals, Inc.)

^○Katsuhiko HAGI¹, Tadashi NOSAKA¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., 2. Sunovion Pharmaceuticals, Inc.)

^○Yutaro SUZUKI¹, Takuro SADI², Manabu YAMAZAKI³, Kazutaka SHIMODA⁴, Takao MORI³, Yuji OZEKI⁵, Hiroshi MATSUDA³, Kurefu OKAMOTO³, Toyoaki SAGAE⁶, Norio SUGAWARA⁴, Norio FURUKORI⁴, Toshiyuki SOMEYA² (1. Suehirobashi hospital, Niigata, Japan, 2. Department of Psychiatry, NiigataUniversity Graduate School of Medical and Dental Sciences, 3. S, 4. S, 5. S, 6. S)

^○Goyo NAGAI¹, Takeshi SUZUKI², Shoko KAGAWA¹, Akifumi NAKAMURA^{1, 3}, Kenji NEMOTO^{1, 4}, Kazuo MIHARA¹, Tsuyoshi KONDO¹ (1. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, 2. Department of Hospital Parmacy, Graduate School of Medicine, University of the Ryukyus, 3. Akari Clinic, 4. Nemoto Clinic)

^○Naotaka SUNADA¹, Yoshiteru TAKEKITA¹, Yosuke KOSHIKAWA¹, Haruhiko OGATA¹, Shinpei NONEN², Chikashi TAKANO¹, Toshiya FUNATSUKI¹, Tomoyo YANAGIDA¹, Minami NAITO¹, Atsuko YAMAMOTO¹, Shiho SAKAI¹, Masataka WAKENO¹, Toshihiko KINOSHITA¹, Masaki KATO¹ (1. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan, 2. Department of Medical Pharmacy, Hyogo University of Health Sciences, Hyogo, Japan)

^○Yasuhisa ABE¹, Ryuuta FUKUNAGA¹, Setsuko YASUGAWA^{1, 2}, Kenshirou MIYAMOTO¹ (1. Yatushiro Kousei Hospital, 2. Kumamoto family mental clinic)

^○Yosuke KOSHIKAWA, Masaki KATO, Nobuatsu AOKI, Yoshiteru TAKEKITA, Minami NAITO, Toshihiko KINOSHITA (Department of Neuropsychiatry. Kansai Medical University)

^○Tadashi NOSAKA¹, Katsuhiko HAGI¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)

^○Tadashi NOSAKA¹, Katsuhiko HAGI¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)

^○Tadashi NOSAKA¹, Katsuhiko HAGI¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)

^○Keisuke ASANO^{1, 2}, Takefumi SUZUKI^{1, 3}, Akira NISHI², Aki ENDO², Ai GOUNARIDIS², Masaru MIMURA², Hiroyuki UCHIDA² (1. Department of Psychiatry, Inokashira Hospital, Tokyo, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Department of Neuropsychiatry and Clinical Ethics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan)

^○Yusuke MURATA, Masayoshi MORI, Hiroki TERAI, Kenji OHE, Munechika ENJOJI (Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan)

^○Kazuhiro TORIYAMA¹, Tomomi MIKAMI², Yoshihisa SATOU³, Takayoshi SASAJIMA² (1. Medical division, Novartis Pharma K.K., Tokyo Japan, 2. Japan Development, Novartis Pharma K.K., Tokyo Japan, 3. Regulatory Office, Novartis Pharma K.K., Tokyo Japan)

^○Akihide WAKAMATSU, Takeshi KOYAMA, Hirokazu KAWAMATA, Akiko FUJINO, Rami SUZUKI (Janssen Pharmaceuticals KK)

^○Kohei KITAGAWA¹, Ryuhei SO², Nobuyuki NOMURA^{3, 4}, Yuya MIZUNO⁵, Hiroyuki UCHIDA³, Fuminari MISAWA⁴, Masafumi KODAMA^{1, 2}, Hiroyoshi TAKEUCHI³ (1. Department of Clinical Research, Okayama Psychiatric Medical Center, 2. Department of Psychiatry, Okayama Psychiatric Medical Center, 3. Department of Neuropsychiatry, Keio University School of Medicine, 4. Department of Psychiatry, Yamanashi Prefectural Kita Hospital, 5. Institute of Psychiatry, Psychology and Neuroscience, King's College London)

^○Sayaka AISO¹, Sakura SONEHARA², Saori KAWAMATA², Shuichi HIRAOKA¹, Ryosuke HARA², Yasuhiro IWAMA³, Katsuyoshi SUZUKI², Daisuke MATSUI² (1. Meiji Seika Pharma Co.,Ltd. Medical Science Sect., 2. Meiji Seika Pharma Co.,Ltd. Safety Vigilance & Management Dept., 3. Meiji Seika Pharma Co.,Ltd. Regulatory Affairs ＆ Clinical Data Science Dept.)

^○Atsuhiro MIYAZAWA, Masaomi IYO, Nobuhisa KANAHARA, Yusuke NAKATA (Department of Psychiatry, Chiba University Hospital)

^○Sho HORIKOSHI^{1, 2}, Itaru MIURA², Mizue ICHINOSE^{2, 3}, Shinnosuke YAMAMOTO^{2, 4}, Masashi ITO^{2, 5}, Taishi ASANO², Chihiro YAMAMOTO⁶, Kenya WATANABE⁶, Keiko NOZAKI², Haruka KANEKO^{2, 3}, Hirooki YABE² (1. Horikoshi mental and physical clinic, 2. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan, 3. Hoshigaoka Hospital, Fukushima, Japan, 4. Fukushima Red Cross Hospital, Fukushima, Japan, 5. Yabuki Hospital, Fukushima, Japan, 6. Department of Pharmacy, Fukushima Medical University Hospital, Fukushima, Japan)

^○Hikaru HORI, Asuka KATSUKI, Kiyokazu ATAKE, Ryohei IGATA, Yuki KONISHI, Reiji YOSHIMURA (Department of psychiatry, school of medicine, University of Occupational and Environmental Health, Kitakyushu, Japan)

^○Ken INADA¹, Jun ISHIGOOKA², Sakiko YAMADA³, Hisashi AKIYOSHI³, Shuichi IWASHITA³, Tomohiro USAMI³ (1. Tokyo Women's Medical University, Tokyo, Japan, 2. Institute of CNS Pharmacology, Tokyo, Japan, 3. Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan)

^○Masaki KATO¹, Yuko ASAMI², Dalia WAJSBROT⁴, Matthieu BOUCHER³, Rita PRIETO⁵, Xuemei WANG⁶, Elizabeth PAPPADOPULOS⁴ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Pfizer Japan Inc., Tokyo, Japan, 3. Pfizer Canada Inc., Kirkland, QC, Canada and McGill University, Montréal, QC, Canada, 4. Pfizer Inc., New York, NY, USA, 5. Pfizer GEP SLU, Madrid, Spain , 6. Syneos Health Inc., Raleigh)

^○AYANO KASHIHARA¹, Yosuke KOSHIKAWA¹, Yoshiteru TAKEKITA¹, Sakai SHIHO¹, Naotaka SUNADA¹, Hiroki BANDOU², Keiichiro NISHIDA¹, Haruhiko OGATA^{1, 2}, Toshihiko KINOSHITA¹, Masaki KATO¹ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Seishokai Sephiroth Hospital)

^○Saki HATTORI¹, Akira SUDA¹, Ikuko KISHIDA^{1, 2}, Masatoshi MIYAUCHI¹, Yohko SHIRAISHI¹, Mami FUJIBAYASHI³, Natsuki TSUJITA⁴, Norio ISHII², Chie ISHII², Toshio MORITANI⁵ (1. Department of Psychiatry, Yokohama City University School of Medicine, 2. Fujisawa Hospital, 3. Division of Physical and Health Education, Setsunan University, 4. Graduate School of Human and Environmental Studies, Kyoto University, 5. Faculty of General Education, Kyoto Sangyo University)

^○Hiroshi ARINAMI¹, Yuutarou SUZUKI^{1, 2}, Misuzu TAJIRI¹, Nobuto TSUNEYAMA¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences , 2. Suehirobashi Hospital)

^○Minami NAITO, Yosuke KOSHIKAWA, Masaki KATO, Shiho SAKAI, Ai ONOHARA, Naotaka SUNADA, Keiichiro NISHIDA, Masafumi YOSHIMURA, Toshihiko KINOSHITA, Yoshiteru TAKEKITA (Department of Neuropsychiatry, Kansai Medical University)

^○Junzo WATANABE^{1, 2}, Yutaro SUZUKI^{1, 3}, Takuro SUGAI¹, Naoki FUKUI¹, Shin ONO¹, Nobuto TSUNEYAMA¹, Misuzu TAJIRI¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2. Medical Corporation Keiseikai, Shirone-Midorigaoka Hospital, Niigata, Japan, 3. Medical Corporation Keiaikai, Suehirobashi Hospital, Niigata, Japan)

^○Shin ONO¹, Takuro SUGAI², Yutaro SUZUKI², Manabu YAMAZAKI³, Kazutaka SHIMODA⁴, Takao MORI³, Yuji OZEKI⁴, Hiroshi MATSUDA³, Norio SUGAWARA⁵, Norio YASUI-FURUKOR⁵, Kurefu OKAMOTO³, Toyoaki SAGAE⁶, Toshiyuki SOMEYA² (1. Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 3. Japan Psychiatric Hospital Association, Tokyo, Japan, 4. Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan, 5. Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan, 6. Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences Faculty of Health and Nutrition, Yonezawa, Japan)

^○Keisuke NOTO, Yoshihiko MATSUMOTO, Akihito SUZUKI, Ryota KOBAYASHI, Koichi OTANI (Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan)

^○Hideaki SATOU¹, Ryuta FUKUNAGA¹, Setsuko YASUKAWA^{1, 2}, Yasuhisa ABE¹, Kenshirou MIYAMOTO¹ (1. Yatsushiro Kousei Hospital,Kumamoto,Japan, 2. Kumamoto Family Meatal Clinic,Kumamoto,Japan)

^○Nobutaka AYANI, Junko ONO, Anri WATANABE, Nozomu OYA, Jin NARUMOTO (Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan)

^○Takuro SUGAI¹, Yutaro SUZUKI¹, Manabu YAMAZAKI², Kazutaka SHIMODA³, Takao MORI², Yuji OZEKI⁴, Hiroshi MATSUDA², Norio SUGAWARA³, Norio Yasui FURUKORI³, Kurefu OKAMOTO², Toyoaki SAGAE⁵, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2. Japan Psychiatric Hospital Association, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine, 4. Department of Psychiatry, Shiga University of Medical Science, 5. Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences Faculty of Health and Nutrition)